Literature DB >> 27138438

A urologist's perspective on prostate cancer imaging: past, present, and future.

Arvin K George1, Baris Turkbey2,3, Subin G Valayil2, Akhil Muthigi2, Francesca Mertan2,3, Michael Kongnyuy2, Peter A Pinto2.   

Abstract

Prostate cancer is unique in that unlike other solid organ malignancies, only recently has imaging been employed to routinely detect and localize disease. The introduction of transrectal ultrasound was a significant development, transitioning digitally guided prostate biopsies to ultrasound guidance. The arrival of multiparametric MRI has become the next major step, transforming the way Urologist's diagnose, stage, and treat prostate cancer. Recent recommendations against PSA screening have changed the landscape of urologic oncology with the changing needs being reflected in the initiation of additional robust imaging techniques at different time points in prostate cancer care. The current review aims to provide a clinical perspective in the history, current standard of care, and novel imaging modalities in the evaluation of prostate cancer.

Entities:  

Keywords:  Cancer diagnosis; Image-guided biopsy; Imaging; Prostate cancer; Staging

Mesh:

Year:  2016        PMID: 27138438      PMCID: PMC7815163          DOI: 10.1007/s00261-016-0751-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  109 in total

1.  Contrast-ultrasound dispersion imaging for prostate cancer localization by improved spatiotemporal similarity analysis.

Authors:  M P J Kuenen; T A Saidov; H Wijkstra; M Mischi
Journal:  Ultrasound Med Biol       Date:  2013-06-19       Impact factor: 2.998

2.  Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.

Authors:  Geoffrey A Sonn; Christopher P Filson; Edward Chang; Shyam Natarajan; Daniel J Margolis; Malu Macairan; Patricia Lieu; Jiaoti Huang; Frederick J Dorey; Robert E Reiter; Leonard S Marks
Journal:  Urol Oncol       Date:  2014-07-11       Impact factor: 3.498

3.  Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen.

Authors:  F Lee; S Torp-Pedersen; P J Littrup; R D McLeary; T A McHugh; A P Smid; P J Stella; G S Borlaza
Journal:  Radiology       Date:  1989-01       Impact factor: 11.105

4.  Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.

Authors:  Dmitry Volkin; Baris Turkbey; Anthony N Hoang; Soroush Rais-Bahrami; Nitin Yerram; Annerleim Walton-Diaz; Jeffrey W Nix; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  BJU Int       Date:  2014-10-18       Impact factor: 5.588

Review 5.  Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.

Authors:  Laura Evangelista; Andrea Guttilla; Fabio Zattoni; Pier Carlo Muzzio; Filiberto Zattoni
Journal:  Eur Urol       Date:  2012-09-25       Impact factor: 20.096

Review 6.  Imaging approaches with advanced prostate cancer: techniques and timing.

Authors:  David Leung; Saravanan Krishnamoorthy; Lawrence Schwartz; Chaitanya Divgi
Journal:  Can J Urol       Date:  2014-04       Impact factor: 1.344

7.  Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: A prospective, paired-patient study.

Authors:  Daniel N Costa; Qing Yuan; Yin Xi; Neil M Rofsky; Robert E Lenkinski; Yair Lotan; Claus G Roehrborn; Franto Francis; Debbie Travalini; Ivan Pedrosa
Journal:  Urol Oncol       Date:  2016-03-09       Impact factor: 3.498

8.  Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.

Authors:  Harriet C Thoeny; Johannes M Froehlich; Maria Triantafyllou; Juerg Huesler; Lauren J Bains; Peter Vermathen; Achim Fleischmann; Urs E Studer
Journal:  Radiology       Date:  2014-06-02       Impact factor: 11.105

9.  Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.

Authors:  Pierre Nevoux; Adil Ouzzane; Hashim U Ahmed; Mark Emberton; Rodolfo Montironi; Joseph C Presti; Arnauld Villers
Journal:  BJU Int       Date:  2011-12-22       Impact factor: 5.588

10.  Is visual registration equivalent to semiautomated registration in prostate biopsy?

Authors:  Jin Tae Kwak; Cheng William Hong; Peter A Pinto; Molly Williams; Sheng Xu; Jochen Kruecker; Pingkun Yan; Baris Turkbey; Peter L Choyke; Bradford J Wood
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

View more
  11 in total

Review 1.  Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Authors:  Matthew J Watson; Arvin K George; Mahir Maruf; Thomas P Frye; Akhil Muthigi; Michael Kongnyuy; Subin G Valayil; Peter A Pinto
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

2.  Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.

Authors:  Akhil Muthigi; Arvin K George; Abhinav Sidana; Michael Kongnyuy; Richard Simon; Vanessa Moreno; Maria J Merino; Peter L Choyke; Baris Turkbey; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2016-08-28       Impact factor: 7.450

3.  Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.

Authors:  Akhil Muthigi; Abhinav Sidana; Arvin K George; Michael Kongnyuy; Mahir Maruf; Subin Valayil; Bradford J Wood; Peter A Pinto
Journal:  Urol Oncol       Date:  2016-10-12       Impact factor: 3.498

4.  Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.

Authors:  Akhil Muthigi; Abhinav Sidana; Arvin K George; Michael Kongnyuy; Nabeel Shakir; Meet Kadakia; Mahir Maruf; Thomas P Frye; Francesca Mertan; Daniel Su; Maria J Merino; Peter L Choyke; Baris Turkbey; Bradford J Wood; Peter A Pinto
Journal:  Int Urol Nephrol       Date:  2016-06-15       Impact factor: 2.370

5.  Multimodality Image Fusion with PSMA PET/CT and High-Intensity Focused Ultrasound Focal Therapy for Primary Diagnosis and Management of Prostate Cancer: A Planned Research Initiative.

Authors:  Marcia C Javitt; Alexander Kravtsov; Zohar Keidar; Sobhi Abadi; Gilad E Amiel
Journal:  Rambam Maimonides Med J       Date:  2017-10-16

6.  Comparison between multiparametric MRI with and without post - contrast sequences for clinically significant prostate cancer detection.

Authors:  Thais Caldara Mussi; Tatiana Martins; George Caldas Dantas; Rodrigo Gobbo Garcia; Renee Zon Filippi; Gustavo Caserta Lemos; Ronaldo Hueb Baroni
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

Review 7.  Potential of nuclear magnetic resonance metabolomics in the study of prostate cancer.

Authors:  R Ravikanth Reddy; Naranamangalam R Jagannathan
Journal:  Indian J Urol       Date:  2022-04-01

8.  Prediction of Prostate Cancer Disease Aggressiveness Using Bi-Parametric Mri Radiomics.

Authors:  Ana Rodrigues; João Santinha; Bernardo Galvão; Celso Matos; Francisco M Couto; Nickolas Papanikolaou
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

9.  Application Value of Radiomic Nomogram in the Differential Diagnosis of Prostate Cancer and Hyperplasia.

Authors:  Shaogao Gui; Min Lan; Chaoxiong Wang; Si Nie; Bing Fan
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

Review 10.  Lymph node imaging in initial staging of prostate cancer: An overview and update.

Authors:  Jessica G Zarzour; Sam Galgano; Jonathan McConathy; John V Thomas; Soroush Rais-Bahrami
Journal:  World J Radiol       Date:  2017-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.